DEFINITIVE PROXY STATEMENT

Company

Vanda Pharmaceuticals Inc.

Filed

April 2, 2008

Period of Report

May 8, 2008

Accession Number

0000950133-08-001395

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →